A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

NCT03494296 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: patients received D-COP regimen chemotherapy

Sponsor

First Affiliated Hospital of Harbin Medical University